Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context

Autor:	Ángel F. Achurra-Castillo, José Francisco Díaz-Coto, Marlene Guibert-Toledano, Carlo V. Caballero-Uribe, C. Pineda Villaseñor, L. M. H. Mota, M. W. Keiserman, Leonor A Barile-Fabris, Claudio Galarza-Maldonado, Bernardo A. Pons-Estel, F. Irazoque Palazuelos, Graciela S. Alarcón, María H Esteva-Spinetti, J. Chávez-Corrales, Mario H. Cardiel, A. V. Lomonte, Enrique R. Soriano, Loreto Massardo
Rok vydání:	2008
Předmět:	medicine.medical_specialty Latin Americans Anticorps monoclonal Context (language use) Drug Administration Schedule Arthritis Rheumatoid Antibodies Monoclonal Murine-Derived Anti cd20 antibody Rheumatology Internal medicine medicine Humans Pharmacology (medical) Anti cd20 business.industry Contraindications Patient Selection Antibodies Monoclonal medicine.disease Latin America Treatment Outcome Antirheumatic Agents Rheumatoid arthritis Immunology Rituximab business Algorithms medicine.drug
Zdroj:	Rheumatology. 47:1097-1099
ISSN:	1462-0332 1462-0324
DOI:	10.1093/rheumatology/ken015a
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f318e336bde6c5d4b12b15f4f428cba https://doi.org/10.1093/rheumatology/ken015a Zobrazit plný text záznamu